July 1, 2024Open Access

Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database

Key Points

Key points are not available for this paper at this time.

Abstract

Based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database, we analyzed the signals of potential adverse events (AEs) of orlistat in the real world to provide a reference for its safe clinical use.

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper

Cite This Study

Zhu et al. (Mon,) studied this question.

synapsesocial.com/papers/68e61ca7b6db6435875af076 https://doi.org/https://doi.org/10.1016/j.heliyon.2024.e34837

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Body Mass Index, Triglycerides, and Risk of Acute Pancreatitis: A Population-Based Study of 118 000 Individuals2019 · 82 citations
2Serum sickness-like reactions to cefaclor1992 · 112 citations
3Routine Colonoscopy after Acute Uncomplicated Diverticulitis - Challenging a Putative Indication2016 · 48 citations
4[Effect of orlistat therapy on carbohydrate, lipid, vitamin and hormone plasma levels in obese subjects].2004 · 5 citations
5Routine lower gastrointestinal endoscopy for radiographically confirmed acute diverticulitis. In whom and when is it indicated?2018 · 8 citations

KI fragen

Bookmark

View Full Paper